Bringing CNS Members Together to Make Children’s Lives Better


Late Breaking Abstract Submission Portal Open: July 20-August 1 (11:59 PST)

Authors with new study data or developments to report who were unable to submit abstracts by the April deadline are invited to submit abstracts July 20 – August 1.

Late Breaking Abstracts must satisfy one of the two following criteria:

  1. Abstract describes a major clinical trial that is likely to have significant impact on clinical practice, using data unavailable by the regular abstract submission deadline of April 11, 2021. or
  2. Abstract describes a discovery representing a major advance in the field based on critical experiment(s) performed after the regular abstract deadline of April 11, 2021.

Please Begin a Submission Only After

  1. Completely Reading Guidelines and
  2. Final Abstract is Ready to Upload/Submit

Click for Late-Breaking Abstract Submission Portal

Please Note:

  • The Abstract Submission site is independent of the Child Neurology Society.
  • You will be required to create a username and password before beginning a submission. If you submitted an abstract for the 2021 CNS Meeting already in a previous round, you can use the email/username & password you originally created.
    …Note: You may use the same username/password as you have for the Child Neurology Society, however, you will be required to create this independently on the Abstract website.
  • All auto generated emails will appear as they are coming from CNS National Office: (
    …(Some auto generated emails may appear in your spam folder. Please be sure to check your spam folder if you do not receive an email after completing a submission.)


Meeting Registration Information Posted on CNS Website

On-line registration in final testing – Opening Soon (July 22-26)
Watch for launch announcement via eConnections and on CNS Website Annual Meeting Page.

GUIDELINES – Late Breaking Abstracts


  1. CNS Membership not required for abstract submission or presentation.
  2. First Author listed will be required to verify work submitted is their own.
  3. Work submitted on behalf of a company, institution or association (e.g. pharmaceutical company) must be clearly identified as such in “Abstract Addendum” section and/or “Supplementary Information” (Financial Disclosures/Grants)
  4. Multiple submissions allowed. Multiple authors allowed. (Max. 3 submissions per presenting author)
  5. Word Count: 250 (does not include title, authors, or text embedded in graphs or graphics; maximum 2 graphics allowed)
  6. Work presented at other meeting(s) and or recently published will be reviewed; author must identify previous presentation venues and verify work was presented before a substantially different audience in space provided in the submission form.
  7. Abstracts should be broken into four-header format: Objective/Methods/Results/Conclusions
  8. SAVE & FINALIZE when submission is completed. Once your submission is completed, submitter is required to click “Publish” and the submitter will receive a confirmation email to verify completed submission has been received.

Review & Presentation

  1. Abstracts will be reviewed by the CNS Scientific Selection & Program Planning Committee assigned by the committee chairs.
  2. Anonymous review; author ID is not available to reviewers prior to final selection of abstracts.
  3. Notification of acceptance and guidelines for presentation will be emailed to first author on or before August 17, 2021.
  4. Notification of non-acceptance will be emailed to first author on or after August 17, 2021.
  5. Authors presenting papers in platform/plenary session(s) will be required to adhere to ACCME financial disclosure/conflict of interest guidelines as defined by the meeting Joint CME Sponsor, MN Medical Association.
  6. Abstracts accepted for presentation will NOT be published in the2021 Annals of Neurology supplement or the CNS Annual Meeting Program. Abstracts accepted will be cited in the Fall/Annual Meeting edition of CNS Connections and on the CNS website.
  7. Authors of abstracts accepted for presentation are required to register for the 50th Annual CNS Meeting. A registered proxy listed as contributing author may present in the event that the first author is unable to attend.
  8. Authors are responsible for all expenses related to attending and presenting at the meeting. No honoraria will be awarded for poster or platform/plenary presentations.

Meeting Information

Click to see 50th CNS Annual Meeting page.